HYDROXYPROPYL-BETA-CYCLODEXTRIN INCREASES THE AQUEOUS SOLUBILITY AND STABILITY OF PILOCARPINE PRODRUGS

被引:24
作者
JARHO, P [1 ]
URTTI, A [1 ]
JARVINEN, T [1 ]
机构
[1] UNIV KUOPIO,DEPT PHARMACEUT TECHNOL,SF-70211 KUOPIO,FINLAND
关键词
PRODRUG; BISPILOCARPIC ACID DIESTER; HYDROXYPROPYL-BETA-CYCLODEXTRIN; INCLUSION COMPLEX; SOLUBILITY; STABILITY;
D O I
10.1023/A:1016290127371
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The effects of 2-hydroxypropyl-beta-cyclodextrin (HP-beta-CD) on the aqueous solubility and stability of two lipophilic bispilocarpine prodrugs were investigated at pH 7.4. Methods. The solubility of prodrugs was studied by phase-solubility method (0-72.5 mM HP-beta-CD). The stability of one of the prodrugs was investigated as a function of temperature (40 degrees C-70 degrees C) and HP-beta-CD concentration (0-72.5 mM). The apparent rate constants (k(1), k(2)) for degradation of prodrug in I:1 and 1:2 inclusion complexes and apparent stability constants (K-1:1, K-1:2) were calculated by the curve-fitting method. Results. The phase-solubility diagrams were classified as A(p)-type and the apparent stability constants (K-1:1, K-1:2) for 1:1- and 1:2-inclusion complexes were calculated to be 143-815 M(-1) and 29-825 M(-1), respectively. The stability of prodrug increased as a function of HP-beta-CD concentration over the studied temperature range. The shelf-life (t(90%), calculated by the Arrhenius equation) of the prodrug in 72.5 mM HP-beta-CD solution increased 5.1-fold and 6.1-fold at 25 degrees C and 4 degrees C, respectively. Conclusions. The solubility of the prodrugs was shown to increase markedly in phase-solubility studies. The degradation rate of prodrug in stability studies was shown to be slower in the 1:2-complex than in the I:l-complex and the relative amounts of complex species were found to be dependent on CD concentration.
引用
收藏
页码:1371 / 1375
页数:5
相关论文
共 17 条
[1]   PILOCARPINE PRODRUGS .2. SYNTHESIS, STABILITY, BIOCONVERSION, AND PHYSICOCHEMICAL PROPERTIES OF SEQUENTIALLY LABILE PILOCARPINE ACID DIESTERS [J].
BUNDGAARD, H ;
FALCH, E ;
LARSEN, C ;
MOSHER, GL ;
MIKKELSON, TJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (08) :775-783
[2]  
DOORNE H, 1993, EUR J PHARM BIOPHARM, V39, P133
[3]   NEW WATER-SOLUBLE PILOCARPINE DERIVATIVES WITH ENHANCED AND SUSTAINED MUSCARINIC ACTIVITY [J].
DRUZGALA, P ;
WINWOOD, D ;
DREWNIAKDEYRUP, M ;
SMITH, S ;
BODOR, N ;
KAMINSKI, JJ .
PHARMACEUTICAL RESEARCH, 1992, 9 (03) :372-377
[4]   BETA-CYCLODEXTRINS ENHANCE BIOAVAILABILITY OF PILOCARPINE [J].
FREEDMAN, KA ;
KLEIN, JW ;
CROSSON, CE .
CURRENT EYE RESEARCH, 1993, 12 (07) :641-647
[5]  
Higuchi T., 1965, PHASE SOLUBILITY TEC, V4, P117
[6]  
JARVINEN K, 1994, CURR EYE RES, V13, P891
[7]   O,O'-(1,4-XYLYLENE) BISPILOCARPIC ACID-ESTERS AS NEW POTENTIAL DOUBLE PRODRUGS OF PILOCARPINE FOR IMPROVED OCULAR DELIVERY .2. PHYSICOCHEMICAL PROPERTIES, STABILITY, SOLUBILITY AND ENZYMATIC-HYDROLYSIS [J].
JARVINEN, T ;
SUHONEN, P ;
URTTI, A ;
PEURA, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 75 (2-3) :259-269
[8]   O,O'-(1,4-XYLYLENE)BISPILOCARPIC ACID-ESTERS AS NEW POTENTIAL DOUBLE PRODRUGS OF PILOCARPINE FOR IMPROVED OCULAR DELIVERY .1. SYNTHESIS AND ANALYSIS [J].
JARVINEN, T ;
SUHONEN, P ;
AURIOLA, S ;
VEPSALAINEN, J ;
URTII, A ;
PEURA, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 75 (2-3) :249-258
[9]  
JARVINEN T, 1995, IN PRESS J OCUL PHAR
[10]  
JARVINEN T, 1992, THESIS U KUOPIO FINL